scholarly article | Q13442814 |
P50 | author | Janne Lehtiö | Q37384646 |
Maria Pernemalm | Q50285787 | ||
Hirsh Koyi | Q57305125 | ||
Lukas M Orre | Q81444732 | ||
Rolf Lewensohn | Q114420426 | ||
Lena Kanter | Q116997587 | ||
P2093 | author name string | Luigi De Petris | |
P433 | issue | 3 | |
P921 | main subject | lung cancer | Q47912 |
P304 | page(s) | 410-417 | |
P577 | publication date | 2008-07-11 | |
P1433 | published in | Lung Cancer | Q641464 |
P1476 | title | Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer | |
P478 | volume | 63 |
Q90288697 | A comprehensive pipeline for translational top-down proteomics from a single blood draw |
Q28385552 | A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma |
Q38258912 | Annexin A2 complexes with S100 proteins: structure, function and pharmacological manipulation. |
Q38478863 | Changes in protein expression in rat bronchoalveolar lavage fluid after exposure to zinc oxide nanoparticles: an iTRAQ proteomic approach. |
Q41421784 | Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages |
Q44086437 | Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma |
Q55495092 | Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer. |
Q51596002 | Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer. |
Q39202347 | Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel |
Q37697035 | Evaluation of potential interactions between the metastasis-associated protein S100A4 and the tumor suppressor protein p53. |
Q34361505 | Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer |
Q44892815 | High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer |
Q28743151 | Identification of novel molecular targets for endometrial cancer using a drill-down LC-MS/MS approach with iTRAQ |
Q53081345 | Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. |
Q35389059 | Lung cancer proteomics: recent advances in biomarker discovery |
Q34350615 | Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery |
Q34109148 | Matrix-assisted laser desorption/ionization mass spectrometry reveals decreased calcylcin expression in small cell lung cancer |
Q35038432 | Osteopontin is a prognostic biomarker in non-small cell lung cancer |
Q50543875 | Prognostic impact of S100A9 overexpression in non-small cell lung cancer. |
Q37730532 | Progress in Top-Down Proteomics and the Analysis of Proteoforms |
Q38100750 | Proteomic biomarkers in lung cancer |
Q37650123 | S100 protein family in human cancer |
Q24294804 | S100A4 interacts with p53 in the nucleus and promotes p53 degradation |
Q34033456 | S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. |
Q38748164 | S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway. |
Q33514817 | Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients |
Q33720233 | Systems biology approaches to develop innovative strategies for lung cancer therapy |
Q50551664 | The S100A6 calcium-binding protein regulates endothelial cell-cycle progression and senescence. |
Q43678811 | Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma. |
Search more.